4//SEC Filing
Cheruvu Pavan 4
Accession 0001209191-19-037525
CIK 0001636050other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 7:09 PM ET
Size
5.4 KB
Accession
0001209191-19-037525
Insider Transaction Report
Form 4
Cheruvu Pavan
Chief Executive Officer
Transactions
- Purchase
Common Stock
2019-06-14$5.21/sh+7,500$39,075→ 7,500 total
Footnotes (1)
- [F1]The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.9798 to $5.35 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
Axovant Gene Therapies Ltd.
CIK 0001636050
Entity typeother
Related Parties
1- filerCIK 0001731741
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 7:09 PM ET
- Size
- 5.4 KB